PriceSensitive

Respiri (ASX:RSH) signs merchant agreement with Zip Co (ASX:Z1P) subsidiary

Health Care
ASX:RSH      MCAP $33.91M
20 July 2020 14:00 (AEST)
Respiri (ASX:RSH) - Ambassador, Michael Clarke

Source: Respiri

Respiri (RSH) has signed a merchant services agreement with buy now, pay later giant Zip Co’s (Z1P) subsidiary, Zip Money Payments.

Respiri is an e-Health software-as-a-solution (SaaS) company supporting respiratory health management.

Its world-first technology detects wheezing, which is a typical symptom of asthma, chronic obstructive pulmonary disease (COPD) and respiratory disease to accurately measure airway limitations.

This agreement follows a recently signed exclusive international sales agreement with Cipla Australia.

Under the agreement, Cipla will order at least 2000 wheezo devices from Respiri.

“The recently announced pharmacy sales and marketing, distribution and logistics agreement with Cipla Australia is expected to significantly increase both pharmacy awareness and patient access to our proprietary wheezo device alongside our training and education initiatives with the Pharmacy Guild of Australia,” CEO Marjan Mikel said.

Respiri considers the latest agreement a way to provide people, no matter their financial situation, with its wheezo device.

“Our agreement with ZIP provides asthmatic patients seeking access to our platform additional financial flexibility when making these important healthcare decisions relating to improvements in the management of their disease,” Marjan stated.

Buy now, pay later services are on the rise in the Australian pharmacy segment; around one in 10 of the general population now utilise flexible payment options.

Company shares are up 13.8 per cent and are trading for 16.5 cents each at 1:12 pm AEST.

Related News